openPR Logo
Press release

Erectile Dysfunction Drugs Market Sets New Record, Projected at USD 5.1 billion by 2032 at 6.5% CAGR

10-18-2023 08:34 AM CET | Health & Medicine

Press release from: Allie Market Research

Erectile Dysfunction Drugs Market

Erectile Dysfunction Drugs Market

Allied Market Research published a report, titled, "Erectile Dysfunction Drugs Market By Product (Sildenafil, Avanfil, Tadalafil, Udenafil, and Others.), By Mode of Administration (Oral Medications and Injectable Medication), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2022-2032." According to the report, the global erectile dysfunction drugs industry was estimated at USD 2.6 billion in 2022 and is anticipated to hit USD 5.1 billion by 2032, registering a CAGR of 6.5% from 2023 to 2032.

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

๐–๐ก๐š๐ญ ๐š๐ซ๐ž ๐ญ๐ก๐ž ๐Ÿ๐š๐œ๐ญ๐จ๐ซ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ญ๐ก๐ž ๐„๐ซ๐ž๐œ๐ญ๐ข๐ฅ๐ž ๐ƒ๐ฒ๐ฌ๐Ÿ๐ฎ๐ง๐œ๐ญ๐ข๐จ๐ง ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ?

The global erectile dysfunction drugs market is driven by factors such as an Increase in the prevalence of erectile dysfunction due to diabetes, obesity, and sedentary lifestyle, easy accessibility of erectile dysfunction drugs, and surge in awareness about erectile dysfunction. However, side effects associated with erectile dysfunction drugs such as nasal congestion, blurred vision, and flushing are hampering the erectile dysfunction drugs market growth. On the contrary, an increase in R&D activities in erectile dysfunction treatment, high growth potential in developing countries, and a rise in new erectile dysfunction drugs launch are expected to offer remunerative opportunities for expansion of the erectile dysfunction drugs market during the forecast period.

๐†๐ž๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐†๐ซ๐š๐ฉ๐ก๐ฌ ๐š๐ง๐ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ ๐‡๐ž๐ซ๐ž: https://www.alliedmarketresearch.com/request-sample/382

๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ ๐จ๐Ÿ ๐‚๐จ๐ฏ๐ข๐-๐Ÿ๐Ÿ— ๐จ๐ง ๐„๐ซ๐ž๐œ๐ญ๐ข๐ฅ๐ž ๐ƒ๐ฒ๐ฌ๐Ÿ๐ฎ๐ง๐œ๐ญ๐ข๐จ๐ง ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:

โ€ข The outbreak of the COVID-19 pandemic had a positive impact on the erectile dysfunction drugs market due to the increased sales of erectile dysfunction drugs.
โ€ข On the other hand, as the global situation started ameliorating, the demand for erectile dysfunction drugs increased, and the rise in product launches and product approvals further contributed toward the market growth. This, in turn, presented various growth opportunities for companies operating in the erectile dysfunction drugs market.

๐“๐จ๐ฉ ๐„๐ซ๐ž๐œ๐ญ๐ข๐ฅ๐ž ๐ƒ๐ฒ๐ฌ๐Ÿ๐ฎ๐ง๐œ๐ญ๐ข๐จ๐ง ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ:-

โ€ข Pfizer Inc.
โ€ข Eli Lilly and Company
โ€ข Teva Pharmaceutical Industries Ltd.
โ€ข Sanofi
โ€ข Bayer AG
โ€ข Vivus LLC.
โ€ข Adamed
โ€ข Glenmark Pharmaceuticals Limited
โ€ข Cipla Ltd
โ€ข Sun Pharmaceutical Industries Limited

๐†๐ฅ๐จ๐›๐š๐ฅ ๐„๐ซ๐ž๐œ๐ญ๐ข๐ฅ๐ž ๐ƒ๐ฒ๐ฌ๐Ÿ๐ฎ๐ง๐œ๐ญ๐ข๐จ๐ง ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:-

Based on product, the sildenafil segment held the highest market share in 2022, accounting for more than half of the global erectile dysfunction drugs market revenue and is estimated to maintain its leadership status throughout the forecast period. The same segment is projected to manifest the highest CAGR of 7.1% from 2023 to 2032. This is because it is easily accessible, highly potent to treat erectile dysfunction, and it is available in various concentrations such as Sildenafil 20mg, sildenafil 50mg, and sildenafil 100mg.

Based on mode of administration, the oral medication segment held the highest market share in 2022, accounting for more than four-fifths of the global erectile dysfunction drugs market revenue and is estimated to dominate the market in terms of revenue during the forecast period. The same segment is estimated to manifest the highest CAGR of 6.8% from 2023 to 2032, owing to increase in demand for oral medications as it is easy to administer, highly effective, and widely available in the market as compared with injectable medication.

Based on the distribution channel, the hospital pharmacy segment accounted for the largest share in 2022, contributing to more than two-fifths of the global erectile dysfunction drugs market revenue and is expected to rule the roost in terms of revenue throughout the forecast timeframe. This segment is projected to maintain the highest CAGR of 7.2% during the forecast period, owing to an increase in the sale of prescription medication from hospitals and the availability of erectile dysfunction drugs in various concentrations through hospital pharmacies.

Based on region, North America held the highest market share in terms of revenue in 2022, accounting for around two-fifths of the global erectile dysfunction drugs market revenue and is estimated to lead the trail throughout the forecast period. The growth is attributed to an increase in accessibility of erectile dysfunction drugs and rise in product approvals. However, the Asia-Pacific region is expected to witness the fastest CAGR of 7.5% from 2023 to 2032, owing to rise in awareness of erectile dysfunction, surge in healthcare expenditure, and an increase in the prevalence of various chronic diseases such as diabetes and obesity.

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/382

Our Market Research Solution Provides You Answer to Below Mentioned Question:

โ€ข Which are the driving factors responsible for the growth of market?
โ€ข Which are the roadblock factors of this market?
โ€ข What are the new opportunities, by which market will grow in coming years?
โ€ข What are the trends of this market?
โ€ข Which are main factors responsible for new product launch?
โ€ข How big is the global & regional market in terms of revenue, sales and production?
โ€ข How far will the market grow in forecast period in terms of revenue, sales and production?
โ€ข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โ€ข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โ€ข Which region has more opportunities?

By Region Outlook

โ€ข North America
(U.S., Canada, Mexico)
โ€ข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โ€ข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โ€ข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Erectile Dysfunction Drugs Market Sets New Record, Projected at USD 5.1 billion by 2032 at 6.5% CAGR here

News-ID: 3254070 • Views: โ€ฆ

More Releases from Allie Market Research

Coal to Liquid Fuel Market Exploring Future Growth 2021-2031 and Key Players - Envidity Energy Inc., Altona Energy
Coal to Liquid Fuel Market Exploring Future Growth 2021-2031 and Key Players - E โ€ฆ
The coal to liquid fuel market size was valued at $3.4 billion in 2021, and coal to liquid fuel industry is estimated to reach $7.7 billion by 2031, growing at a CAGR of 8.7% from 2022 to 2031. ๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:https://www.alliedmarketresearch.com/request-sample/2723 The coal-to-liquid (CTL) fuel market represents a unique sector within the broader energy landscape, offering an alternative route for producing liquid fuels from coal. This process involvesโ€ฆ
C5 Resins Market Projected to Hit $1.2 Billion By 2032 | Growth with Recent Trends & Demand
C5 Resins Market Projected to Hit $1.2 Billion By 2032 | Growth with Recent Tren โ€ฆ
According to the report, the C5 resin market valued for $0.8 billion in 2022 and is estimated to reach $1.2 billion by 2032, exhibiting a CAGR of 4.5% from 2023 to 2032. Request PDF Brochure: https://www.alliedmarketresearch.com/request-sample/75073 Prime determinants of growth- The global C5 resins market is driven by factors such as, an increase in demand for sealant and adhesive from the packaging industry, and an upsurge inโ€ฆ
Breathing Life into Sustainability: Exploring the Carbon Dioxide Market Landscape by 2031
Breathing Life into Sustainability: Exploring the Carbon Dioxide Market Landscap โ€ฆ
Allied Market Research recently unveiled an extensive report titled "Chemical Technology Market," covering a spectrum of technologies including Artificial Intelligence, Sodium-Ion Batteries, Nanozymes, Blockchain, Nanosensors, Nanopesticides, Metal Organic Frameworks (MFOs), 3D-Printing, and more. The report also explores applications such as Petrochemicals and Polymers, Fertilizers and Agrochemicals, among others. According to the report, the global chemical technology industry attained a valuation of $1.4 billion in 2021 and is anticipated to reachโ€ฆ
Emission Monitoring System Market: Top Manufacturers, Industry Growth, and Development Factors by 2031 | Growing at a CAGR of 8.8%
Emission Monitoring System Market: Top Manufacturers, Industry Growth, and Devel โ€ฆ
Allied Market Research published a report on the Emission Monitoring System Market by Component (Hardware, Services), by End-User (Industrial, Energy and Utilities, Others), by System Type (CEMS, PEMS): Global Opportunity Analysis and Industry Forecast, 2021-2031. The global emission monitoring system market was valued at $3.8 billion in 2021, and is projected to reach $8.7 billion by 2031, growing at a CAGR of 8.8% from 2022 to 2031. Download Report Sampleโ€ฆ

All 5 Releases


More Releases for Erectile

Global Erectile Dysfunction Devices Market Report
As per GME studies, on the Global Erectile Dysfunction Devices Market, it is analyzed that the market will grow at a CAGR of 6.5%. Erectile dysfunction incidence increases with growing age, about 5-10% of men under 40 years are the possible suspects for the dysfunctionality. This is projected to drive the ED device market in the coming years also. Raising the aforementioned disease prevalence and the growing percentage of tobaccoโ€ฆ
50 Open Clinical Studies Presently, To Treat Erectile Dysfunction To Boost The E โ€ฆ
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a ratioโ€ฆ
Erectile Dysfunction Drugs Market Size, Erectile Dysfunction Drugsmarket Share, โ€ฆ
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025. Request for Sample of This Research Report @ https://bit.ly/2NXzatD Top Key Players:- Bayer AG Pfizer Eli Lilly & Co. Vivus, Inc. S.K. Chemicals Co. Ltd. Dong-A Pharmaceutical Co. Ltd Meda Pharmaceuticals Apricus Biosciences Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying According to a new study published by Polaris Market Research the global erectile dysfunctionโ€ฆ
Erectile Dysfunction Market Industry Forecast till 2024
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with aโ€ฆ
Erectile Dysfunction: A Prominent Age Related Disorder
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with aโ€ฆ
Erectile Dysfunction - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as โ€œErectile Dysfunction - Pipeline Review, H2 2017โ€.ย Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246564 The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol use and medications, including antidepressants,โ€ฆ